Area Abbonati


Cancer during pregnancy: what is the role of maternal serum and placental biomarkers? A review and commentary
Gerald J Mizejewski
Tumori 2014;100(6):581-589 | DOI 10.1700/1778.19254
Abstract | € 20 Acquista articolo

Antioxidant strategies in genetic syndromes with high neoplastic risk in infant age
Cecilia Anichini, Federica Lotti, Mariangela Longini, Cosetta Felici, Fabrizio Proietti, Giuseppe Buonocore
Tumori 2014;100(6):590-599 | DOI 10.1700/1778.19256
FREEFull Text | PDF (173,5 kb)


Management of contralateral axillary lymph node metastasis from breast cancer: a clinical dilemma
Wenmiao Wang, Peng Yuan, Jiayu Wang, Fei Ma, Pin Zhang, Qing Li, Binghe Xu
Tumori 2014;100(6):600-604 | DOI 10.1700/1778.19258
Abstract | € 20 Acquista articolo

Retreatment with trastuzumab after progression on lapatinib-based therapy in heavily pretreated HER2-positive metastatic breast cancer: a single-institution experience
Paolo Carli, Loredana Militello, Gian Maria Miolo, Daniela Quitadamo, Davide Lombardi, Elena Torrisi, Simona Scalone, Diana Crivellari, Simon Spazzapan
Tumori 2014;100(6):605-611 | DOI 10.1700/1778.19260
Abstract | € 20 Acquista articolo

Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss)
Stefano Ferrari, Cristina Meazza, Emanuela Palmerini, Angela Tamburini, Franca Fagioli, Raffaele Cozza, Virginia Ferraresi, Gianni Bisogno, Maurizio Mascarin, Graziella Cefalo, Marco Manfrini, Rodolfo Capanna, Roberto Biagini, Davide Donati, Piero Picci
Tumori 2014;100(6):612-619 | DOI 10.1700/1778.19262
FREEFull Text | PDF (573,5 kb)

A prospective randomised study of transvaginal ultrasound effects of tamoxifen and exemestane in postmenopausal women with early breast cancer
Ornella Garrone, Gianfilippo Bertelli, Ernesto Principe, Paul D Lewis, Marcella Occelli, Emanuela Miraglio, Marco C Merlano
Tumori 2014;100(6):620-624 | DOI 10.1700/1778.19264
Abstract | € 20 Acquista articolo


Twenty years of radiobiology in clinical practice: the Italian contribution
Lidia Strigari, Rocchina Caivano, Michele Avanzo, Marta Cremonesi, Cecilia Arrichiello, Carla Bianchi, Francesca Botta, Giorgia Califano, Nunzia Ciscognetti, Daniela D’Alessio, Laura D’Ambrosio, Marco D’Andrea, Daniela Falco, Francesco Guerriero, Maria Guerrisi, Domenico Mola, Maria Cristina Pressello, Anna Sarnelli, Luigi Spiazzi, Angela Terlizzi, Marcello Benassi, Piernicola Pedicini
Tumori 2014;100(6):625-635 | DOI 10.1700/1778.19266
Abstract | € 20 Acquista articolo

Impact of 11C-methionine positron emission tomography/computed tomography on radiation therapy planning and prognosis in patients with primary brain tumors
Mink Schinkelshoek, Egesta Lopci, Elena Clerici, Filippo Alongi, Pietro Mancosu, Marcello Rodari, Pierina Navarria, Bernies van der Hiel, Marta Scorsetti, Arturo Chiti
Tumori 2014;100(6):636-644 | DOI 10.1700/1778.19268
FREEFull Text | PDF (406,2 kb)

Child-Pugh score maintenance in cirrhotic hepatocellular carcinoma patients after radiotherapy: aspects of gastroduodenal complications
Jeong Il Yu, Ju-Yeon Cho, Hee Chul Park, Do Hoon Lim, Geum-Youn Gwak, Seung Woon Paik
Tumori 2014;100(6):645-651 | DOI 10.1700/1778.19270
Abstract | € 20 Acquista articolo

IMRT-SIB with concurrent and neo-adjuvant platinum-based chemotherapy for locally advanced head and neck squamous cell cancer: analysis of clinical outcomes in a retrospective series of a single institution
Ercole Mazzeo, Paolo Antognoni, Manuela Parmiggiani, Consuelo D’Ambrosio, Giuseppina De Marco, Laura Marra, Giovanni Gottardi, Filippo Bertoni
Tumori 2014;100(6):652-659 | DOI 10.1700/1778.19272
FREEFull Text | PDF (144,7 kb)


Urinary modified nucleosides as novel biomarkers for diagnosis and prognostic monitoring of urothelial bladder cancer
Yu-Rui Zhang, Lei Shi, Hui Wu, Dong-Dong Tang, Shao-Min Wang, Hong-Min Liu, Li-Rong Zhang, Dong-Kui Song
Tumori 2014;100(6):660-666 | DOI 10.1700/1778.19274
Abstract | € 20 Acquista articolo

Overexpression of MTA1 and loss of KAI-1 and KiSS-1 expressions are associated with invasion, metastasis, and poor-prognosis of gallbladder adenocarcinoma
Wenjun Wang, Zhu-lin Yang, Jie-qiong Liu, Le-ping Yang, Xiao-jing Yang, Xi Fu
Tumori 2014;100(6):667-674 | DOI 10.1700/1778.19276
Abstract | € 20 Acquista articolo


Evaluation of chemoradiotherapy with carbon ions and the influence of p53 mutational status in the colorectal carcinoma cell line HCT 116
Sebastian Adeberg, Daniela Baris, Daniel Habermehl, Stefan Rieken, Stefan Brons, Klaus-Josef Weber, Wilfried Roth, Jürgen Debus, Stephanie E Combs
Tumori 2014;100(6):675-684 | DOI 10.1700/1778.19278
FREEFull Text | PDF (272,0 kb)


The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: highlights from the 7th Meeting of AIRO – Young Members Working Group (AIRO Giovani)
Pierfrancesco Franco, Berardino De Bari, Patrizia Ciammella, Alba Fiorentino, Silvia Chiesa, Dante Amelio, Valentina Pinzi, Pierluigi Bonomo, Stefano Vagge, Michele Fiore, Tiziana Comito, Agnese Cecconi, Gianluca Mortellaro, Alessio Bruni, Marco Trovò, Andrea Riccardo Filippi, Daniela Greto, Filippo Alongi, on behalf of AIRO Giovani (Italian Association of Radiation Oncology, Young Members Working Group)
Tumori 2014;100(6):e214-e229 | DOI 10.1700/1778.19280
Abstract | € 20 Acquista articolo


Extracellular chaperonin 10 augments apoptotic cell death induced by 5-fluorouracil in human colon cancer cells
Kun Kim, Seung-Gu Yeo
Tumori 2014;100(6):e230-e235 | DOI 10.1700/1778.19282
Abstract | € 20 Acquista articolo

The PEDRO (Pocketable Electronic Devices in Radiation Oncology) project: how clinical practice is changing among young radiation oncologists
Berardino De Bari, Pierfrancesco Franco, Patrizia Ciammella, Andrea Peruzzo Cornetto, Daniela Greto, Carla Fundoni, Andrea Riccardo Filippi, Filippo Alongi, on behalf of AIRO Giovani (Italian Association of Radiation Oncology-Young Members Working Group)
Tumori 2014;100(6):e236-e242 | DOI 10.1700/1778.19284
FREEFull Text | PDF (239,0 kb)

Impact of a program for rapid diagnosis and treatment of lung cancer on hospital care delay and tumor stage
Anna Selva, Ignasi Bolíbar, Alfons Torrego, Mª Cinta Pallarès
Tumori 2014;100(6):e243-e249 | DOI 10.1700/1778.19286
Abstract | € 20 Acquista articolo

Evolution of surgery for Klatskin tumor demonstrates improved outcome: a single center analysis
Yongjia Yan, Ning Lu, Weijun Tian, Tong Liu
Tumori 2014;100(6):e250-e256 | DOI 10.1700/1778.19288
Abstract | € 20 Acquista articolo

Hypoxia-inducible factor-1α G polymorphism and the risk of cancer: a meta-analysis
Yanwei Ye, Min Wang, Jingjing Li, Yingqiang Shi, Xiefu Zhang, Ye Zhou, Chunlin Zhao, Jianguo Wen
Tumori 2014;100(6):e257-e265 | DOI 10.1700/1778.19290
Abstract | € 20 Acquista articolo

Correlation between deregulated expression of PER2 gene and degree of glioma malignancy
Fan Wang, Yong Luo, Caiyan Li, lvan Chen
Tumori 2014;100(6):e266-e272 | DOI 10.1700/1778.19292
Abstract | € 20 Acquista articolo

Dynamic expression changes between non-muscle-invasive bladder cancer and muscle-invasive bladder cancer
Yu-gang Zhao, Bing-yi Shi, Ye-yong Qian, Hong-wei Bai, Li Xiao, Xiu-yun He
Tumori 2014;100(6):e273-e281 | DOI 10.1700/1778.19294
Abstract | € 20 Acquista articolo


Rationale and protocol of SOAP: a phase II study to evaluate the efficacy of sorafenib as second-line treatment after pazopanib in patients with advanced renal cell carcinoma
Roberto Iacovelli, Elena Verzoni, Paolo Grassi, Alessio Farcomeni, Filippo de Braud, Giuseppe Procopio
Tumori 2014;100(6):e282-e285 | DOI 10.1700/1778.19296
Abstract | € 20 Acquista articolo

Rationale and protocol of the MetNET-1 trial, a prospective, single center, phase II study to evaluate the activity and safety of everolimus in combination with octreotide LAR and metformin in patients with advanced pancreatic neuroendocrine tumors
Sara Pusceddu, Filippo de Braud, Laura Concas, Cristina Bregant, Livia Leuzzi, Barbara Formisano, Roberto Buzzoni
Tumori 2014;100(6):e286-e289 | DOI 10.1700/1778.19298
Abstract | € 20 Acquista articolo

The ORCHIDEE study: gathering new evidence on the use of everolimus in clinical practice
Mimma Rizzo, Giacomo Cartenì, Giovanni Pappagallo, Lital Hollander, Irene Floriani
Tumori 2014;100(6):e290-e292 | DOI 10.1700/1778.19300
Abstract | € 20 Acquista articolo


Targeted therapy in renal carcinoma: a case of long-term effect with complete control of toxicity
Serafino Conforti, Silvia Ceniti, Ludovica Conforti, Salvatore Turano, Stefano Minardi, Salvatore Palazzo
Tumori 2014;100(6):e293-e297 | DOI 10.1700/1778.19302
Abstract | € 20 Acquista articolo

Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs’ antiangiogenic activity
Giovanni Schinzari, Santa Monterisi, Diego Signorelli, Silvia Cona, Alessandra Cassano, Francesco Danza, Carlo Barone
Tumori 2014;100(6):e298-e300 | DOI 10.1700/1778.19304
Abstract | € 20 Acquista articolo

Good tolerability, long-term survival and easy management of side effects in a patient with metastatic renal cell carcinoma treated with pazopanib
Mara Frascaroli, Pamela Di Cesare
Tumori 2014;100(6):e301-e304 | DOI 10.1700/1778.19306
Abstract | € 20 Acquista articolo

Long-term response to pazopanib in an elderly man with mRCC. A case report
Carmine D’Aniello, Carla Cavaliere, Salvatore Pisconti, Gaetano Facchini
Tumori 2014;100(6):e305-e308 | DOI 10.1700/1778.19308
Abstract | € 20 Acquista articolo


Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study
Michele De Tursi, Consiglia Carella, Silverio Tomao, Saverio Cinieri, Vito Lorusso, Paolo Marchetti, Stefania Vecchio, Elisabetta Sansoni, Antonio Contu, Vincenzo Adamo, Nicola Silvestris, Antonio Nuzzo, Giovanni Rosti, Alberto Ravaioli, Marco Danova, Giuseppe Tonini, Rodolfo Passalacqua, Giorgio Cruciani, Marina Faedi, Massimiliano Spada, Michelino De Laurentiis, Domenico Amoroso, Federica Tomao, Isabella Sperduti, Antonino Grassadonia, Nicola Tinari, Clara Natoli, Stefano Iacobelli, on behalf of CINBO (Consorzio Interuniversitario Nazionale per la Bio-Oncologia)
Tumori 2014;100(6):e309-e313 | DOI 10.1700/1778.19310
Abstract | € 20 Acquista articolo

A Journal of Experimental and Clinical Oncology
Una pubblicazione della Fondazione IRCCS
"Istituto Nazionale dei Tumori"

2014 Vol. 100
N. 6 November-December
AIOM 2013
Intervista video Mario Mandalà
Dip. Oncologia ed Ematologia, Ospedale Papa Giovanni XXIII, Bergamo (VIDEO)
Intervista video Paolo Bruzzi
Unità di Epidemiologia Clinica, Ist. Naz. per la Ricerca sul Cancro, Genova (VIDEO)
Con il contributo incondizionato di
INCONTRI. A colloquio con l'industria
A cura di Giulia Volpe
Intervista video Massimo Verdilio
Oncology Business Unit Director presso Lilly Oncology, Eli Lilly Italia S.p.A. (VIDEO)
Intervista video
Massimo Abbiati

Elekta Italia (PDF: 470 Kb)
Intervista videoAlberto Stanzione
BU Head Pfizer Oncology Italia
(PDF: 370 Kb)